AMIA’s goal is to improve the legislative and regulatory environment for health informatics research, practice and education through AMIA member expertise. The primary pathway through which AMIA achieves this goal is by engaging Federal Agencies and Congress on public calls for input, such as Notices of Proposed Rulemakings (NPRMs) or Request for Information (RFIs).
Learn more about the comment process
AMIA responses are arranged by Federal Agency and Congressional Committee.
On April 6, 2016, AMIA called proposed revisions to substance use disorder (SUD) regulations, also known as 42 CFR Part 2, well-intentioned, but ultimately insufficient. AMIA urged the Department of Health and Human Services (HHS) to lead a national effort to develop technical standards that would enable patients to have […]
On January 26, 2016, AMIA submitted a letter of support for the Office of the National Coordinator for Health Information Technology (ONC) “Private Sector Interoperability Commitments Pledge,” which seeks to bolster interoperability in healthcare by enabling consumer access to their data, improving transparency and encouraging widespread adoption of […]
The following statement was released today by Douglas B. Fridsma, M.D., PhD., FACP, FACMI, President and CEO, American Medical Informatics Association (AMIA).
AMIA appreciates the work and bipartisanship demonstrated by Chairman Alexander, Ranking Member Murray and the entire HELP Committee in crafting the Improving Health Information Technology Act of 2015 […]
On February 1, 2016, AMIA submitted comments to the Centers for Medicare and Medicaid Services making several recommendations of how to improve quality measurement in an electronic environment. The group called for an overhaul to the current process, while looking to specialty societies for expert prioritization.
On January 11, 2016, AMIA submitted comments to the National Qualify Forum’s Health IT Safety Committee, supporting the framework and newly-developed domains to measure the safety and safe use of health IT. Numerous AMIA members participated in this effort, and AMIA believes these measures should serve as a foundation for […]
On January 8, 2016, AMIA submitted comments to the National Center for Advancing Translational Sciences (NCATS) on priority areas the Center should consider when developing its strategic plan. AMIA believes NCATS should focus on (1) developing ways to measure and convey how their programs impact patients and institutions; (2) defining […]
On January 6, 2016 AMIA submitted comments to HHS recommending ways to improve the Federal Policy for the Protection of Human Subjects, also known as the Common Rule. AMIA support many of the updates, and believes they will better enable a learning health system over current policies.
On December 14, AMIA submitted comments to CMS regarding the need to redesign Meaningful Use (MU) in the face of changing reimbursement models. Specifically, AMIA asked regulators to change MU requirements to better align with programs required by the Medicare Access and CHIP Reauthorization Act (MACRA) of 2015.
On June 10, 2015 Dr. Thomas H. Payne, AMIA Board Chair-elect provided testimony to the Senate Health Education Labor & Pensions (HELP) Committee, identifying near-term actions Congress should take to improve health IT interoperability and promote health information exchange. Dr. Payne’s testimony summarized the recently published EHR 2020 Task Force […]